Does Dr. MARINA KUPERMAN-BEADE have financial conflicts of interest?

Dr. MARINA KUPERMAN-BEADE (M.D., F.A.A.D.) has received a total of $659 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $659 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. MARINA KUPERMAN-BEADE?

According to CMS Open Payments data, Dr. MARINA KUPERMAN-BEADE received funding from LEO PHARMA ($161), JANSSEN BIOTECH ($109), and INCYTE CORPORATION ($100).

Does Dr. MARINA KUPERMAN-BEADE receive research grants or speaking fees?

Dr. MARINA KUPERMAN-BEADE has received $659 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. MARINA KUPERMAN-BEADE

M.D., F.A.A.D.Real-Time Hydrated

Specialty: Dermatology, MOHS-Micrographic Surgery

Practice Location: FALL RIVER, MA 02720

NPI Number: 1477572816

LIFETIME INDUSTRY VALUE

$659

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. KUPERMAN-BEADE is a verified Dermatology, MOHS-Micrographic Surgery practitioner based in FALL RIVER, MA.

Between 2021 and 2025, Dr. KUPERMAN-BEADE had an overall industry promotional and research financial footprint of $659 as recorded in the federal CMS Open Payments database.

$659 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. KUPERMAN-BEADE's primary funding source is LEO PHARMA, which accounts for $161 (representing 24.4% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

LEO PHARMA

Rank 1

$161

24.4%

JANSSEN BIOTECH

Rank 2

$109

16.5%

INCYTE CORPORATION

Rank 3

$100

15.3%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.